BioSpace News Archive

Illustration of four arrows changing direction

Career Advice

The biggest career decisions don’t feel like career decisions

The choices that change a career often look like extra work at the time. Executive coach Angela Justice examines why the projects, questions, relationships and conversations people almost dismiss can become the ones they later recognize as turning points.

July 15, 2026

·

5 min read

·

Angela Justice

Paper plane go to success goal vector business financial concept start up, leadership, creative idea symbol paper art style

Earnings

Q2 earnings arrive as pharma picks up steam, buoyed by dealmaking, policy tailwinds

Biopharma is entering its second-quarter earnings season riding high on a wave of massive deals and venture capital flow, plus a clearing of regulatory and policy overhangs. What can industry watchers expect to hear on the upcoming investor calls?

July 15, 2026

·

6 min read

·

Tristan Manalac

Baseball background design. Vector illustration of sports concept

Manufacturing

Manufacturing issues prompt FDA to reject Hengrui-Elevar filings for third time

An inspection of a facility making Elevar’s rivoceranib uncovered deficiencies, leading the FDA to reject a combination therapy that includes the drug. The rebuff is the third strike for the partners after the agency issued manufacturing-related denials for the other drug in the combo.

July 15, 2026

·

1 min read

·

Nick Paul Taylor

Illustration of businessman searching for something with help of AI

Career Advice

Standing out, not blending in: how AI tools can drive impact during job searches

AI tools can help job seekers write resumes and mass apply to open positions, but those aren’t the only, or best, ways to use them. A career coach shares how she advises clients to make the most of AI during the application and interview process.

July 15, 2026

·

3 min read

·

Angela Gabriel

Business

Biotech IPOs surge in H1 of 2026, shattering records and doubling last year’s total

After a sluggish 2025, biotech IPOs have roared back to life. Fueled by resilient stock performances and improving market sentiment, the total number of public debuts so far this year has already eclipsed 2025’s total.

July 15, 2026

·

2 min read

·

Gabrielle Masson

Press Releases

Crescent Biopharma Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

July 15, 2026

·

4 min read

Press Releases

Spur Therapeutics Announces Executive Transitions